www.kirkland.com/news/press-release/2019/01/kirkland-represents-bristol_myers-squibb-on-acquis

Jan 3, 2019 ... Kirkland & Ellis advised Bristol-Myers Squibb Company (NYSE: BMY) on its agreement to acquire Celgene Corporation (NASDAQ: CELG) in a ...

www.kirkland.com/publications/article/2017/12/supreme-courts-decision-in-bms-presents-new-hurdle

Dec 18, 2017 ... One of the biggest U.S. Supreme Court decisions of the past term was the court's June decision in Bristol-Myers Squibb Co. v. Superior Court of ...

www.law.com/2019/02/15/whole-foods-asks-dc-circuit-to-apply-bristol-myers-to-limit-class-action-jurisdiction

Feb 15, 2019 ... The U.S. Court of Appeals for the D.C. Circuit could be the first appeals court to rule on whether Bristol-Myers Squibb v. Superior Court of ...

law.justia.com/cases/federal/appellate-courts/ca6/16-3154/16-3154-2017-10-27.html

Oct 27, 2017 ... Abilify is approved to treat schizophrenia, Bipolar Disorder, major depressive disorder and irritability associated with autism. There are no ...

www.patentdocs.org/2019/02/momenta-pharmaceuticals-inc-v-bristol-myers-squibb-co-fed-cir-2019.html

Feb 7, 2019 ... By Kevin E. Noonan -- The Federal Circuit has on several occasions taken the opportunity to address (and in doing so, flesh out) the ...

www.cafc.uscourts.gov/sites/default/files/opinions-orders/17-1694.Opinion.2-7-2019.pdf

Feb 7, 2019 ... name “abatacept” and the BMS brand name Orencia®. 1. Momenta Pharm., Inc. v . Bristol-Myers Squibb Co.,. 2016 WL 7987985 (P.T.A.B. Dec.

news.bloomberglaw.com/health-law-and-business/kirkland-advises-bristol-myers-squibb-on-74-b-celgene-buy-1?utm_source=rss&utm_medium=HLNW&utm_campaign=00000168-1440-dade-a57b-5fc6f0e20002

Jan 3, 2019 ... Kirkland Advises Bristol-Myers Squibb on $74 B Celgene Buy (1) ... Those attorneys came from Wachtell's corporate, executive compensation, ...